Lab automation sales will expand through 2036, with biochemistry devices and molecular devices remaining key device categories in 2026. Life sciences research and drug discovery stay major application areas. The market is likely to stand at USD 2.7 billion in 2026 and total USD 6.9 billion by 2036.